Paion Competitors and Similar CompaniesClear all
Array BioPharma's competitors and similar companies include Affimed N.V. and Avid Bioservices.
 Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. |  Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | |
Founding Date | Founding Date 1998 | Founding Date 2000 | Founding Date 1981 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations Heidelberg, DE HQ | Locations Tustin, US HQ |
Employees | Employees 110 | Employees 76 | Employees 21114% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 52.5 m | Valuation ($) 649.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $139.9m (FY, 2024) |
Cost of goods | Cost of goods $59.4m (FY, 2018) | Cost of goods N/A | Cost of goods $132.6m (FY, 2024) |
Gross profit | Gross profit $114.4m (FY, 2018) | Gross profit €13m (FY, 2023) | Gross profit $7.3m (FY, 2024) |
Net income | Net income ($147.7m) (FY, 2018) | Net income (€105.9m) (FY, 2023) | Net income ($140.8m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Affimed N.V.
HQ
Heidelberg, DE
Employees
76
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View companyAvid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company